News
1h
Zacks Investment Research on MSNSlowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results